---
figid: PMC9452720__fphar-13-961941-g001
figtitle: How zoledronic acid improves osteoporosis by acting on osteoclasts
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC9452720
filename: fphar-13-961941-g001.jpg
figlink: /pmc/articles/PMC9452720/figure/F1/
number: F1
caption: ZA can inhibit the RANKL/RANK signaling pathway. The bind of RANKL and RANK
  can activate a series of signaling pathways, such as nuclear factor kappa B (NF-κB)
  pathway, mitogen-activated protein kinases (MAPK) pathway, and AMP-activated protein
  kinase (AMPK) pathway. These signaling pathways can in turn cause tartrate-resistant
  acid phosphatase (TRAP), c-Jun, c-Fos, nuclear factor of activation of T cells-1
  (NFATc1), c-Jun N-terminal kinase (JNK), dendritic cell Expression of specific transmembrane
  protein (DC-STAMP), spleen tyrosine kinase (SYK), cathepsin K (CTSK) and other signaling
  molecules. It is through the RANKL/RANK signaling pathway that ZA regulates the
  expression of these signaling pathways and signaling molecules to inhibit osteoclast
  differentiation and bone resorption.
papertitle: How zoledronic acid improves osteoporosis by acting on osteoclasts.
reftext: Biao Wang, et al. Front Pharmacol. 2022;13:961941.
year: '2022'
doi: 10.3389/fphar.2022.961941
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: osteoporosis | zoledronic acid | osteoclasts | differentiation | apoptosis
  | signaling | signaling pathways
automl_pathway: 0.9397709
figid_alias: PMC9452720__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC9452720__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9452720__fphar-13-961941-g001.html
  '@type': Dataset
  description: ZA can inhibit the RANKL/RANK signaling pathway. The bind of RANKL
    and RANK can activate a series of signaling pathways, such as nuclear factor kappa
    B (NF-κB) pathway, mitogen-activated protein kinases (MAPK) pathway, and AMP-activated
    protein kinase (AMPK) pathway. These signaling pathways can in turn cause tartrate-resistant
    acid phosphatase (TRAP), c-Jun, c-Fos, nuclear factor of activation of T cells-1
    (NFATc1), c-Jun N-terminal kinase (JNK), dendritic cell Expression of specific
    transmembrane protein (DC-STAMP), spleen tyrosine kinase (SYK), cathepsin K (CTSK)
    and other signaling molecules. It is through the RANKL/RANK signaling pathway
    that ZA regulates the expression of these signaling pathways and signaling molecules
    to inhibit osteoclast differentiation and bone resorption.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - TRAF6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TNFSF11
  - TNFRSF11A
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - IK
  - EPHB2
  - CALCR
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - JUN
  - JUNB
  - JUND
  - CTSK
  - Nfkb1
  - Traf6
  - Tnfsf11
  - Tnfrsf11a
  - ba
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Rela
  - Gorasp1
  - Ik
  - Ephb2
  - Mapk1
  - Calcr
  - Fos
  - Acp5
  - Ssr4
  - Cd40
  - Cd40lg
  - Jun
  - Ctsk
  - Syt1
  - Prkaa2
  - Ephb1
---
